INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 59 filers reported holding INSTIL BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,585,000 | -3.3% | 2,393,683 | -7.7% | 0.14% | +3.6% |
| Q2 2022 | $11,983,000 | -16.4% | 2,593,781 | +94.5% | 0.14% | +9.6% |
| Q1 2022 | $14,332,000 | -35.1% | 1,333,227 | +3.4% | 0.12% | -29.4% |
| Q4 2021 | $22,070,000 | -2.5% | 1,289,899 | +1.9% | 0.18% | 0.0% |
| Q3 2021 | $22,640,000 | +77.1% | 1,266,271 | +11.2% | 0.18% | +84.4% |
| Q2 2021 | $12,782,000 | -52.6% | 1,138,705 | +6.0% | 0.10% | -52.5% |
| Q1 2021 | $26,953,000 | – | 1,074,700 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $649,839,000 | 100.00% |
| CPMG Inc | 8,478,790 | $145,072,000 | 26.75% |
| VR Adviser, LLC | 6,865,076 | $117,461,000 | 16.06% |
| Vivo Capital, LLC | 12,486,787 | $213,649,000 | 12.88% |
| Samsara BioCapital, LLC | 1,991,950 | $34,082,000 | 6.61% |
| Fairmount Funds Management LLC | 673,905 | $11,531,000 | 3.80% |
| RA Capital Management | 4,870,793 | $83,339,000 | 1.47% |
| Parametrica Management Ltd | 50,699 | $867,000 | 0.86% |
| HighVista Strategies LLC | 56,901 | $974,000 | 0.78% |
| Nicholas Investment Partners, LP | 713,221 | $12,203,000 | 0.77% |